#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany The Netherlands Poland Spain

  • Study of Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Greece +5

  • Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany The Netherlands Spain

  • Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Ireland Italy Poland +1

  • Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Germany Greece Italy +4

  • Study on the Effectiveness of Talquetamab and Teclistamab in First-Line Treatment for Transplant-Eligible Multiple Myeloma Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Estonia Norway

  • Study on Teclistamab and Drug Combination for Newly Diagnosed Multiple Myeloma Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Venetoclax and Dexamethasone for Patients with Relapsed and Refractory Multiple Myeloma with Translocation (11;14)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +8